Forlong Biotechnology Announced CMC Readiness to Initiate GMP Batch Production to Support Upcoming Pivotal Clinical Trial for FL115 (IL-15 Superagonist) in Nonmuscle Invasive Bladder Cancer (NMIBC) Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients…
NorthStar Secures FDA Acceptance of Drug Master File for No-Carrier-Added Actinium-225 NorthStar Medical Radioisotopes, LLC a leading radiopharmaceutical company, today announced that it received notice of the U.S. Food & Drug Administration’s (FDA) acceptance of its Type II Drug Master…
Litmys and Konovo Form Partnership to Revolutionize Drug Development Intelligence for Life Sciences Companies Litmys, a life sciences commercial strategy consulting firm, specializing in the development of commercial readiness analytics, and Konovo, a technology-first healthcare intelligence company that accelerates access to…
AMGTA Releases Independent Report on Additive Manufacturing’s Role in Resource-Efficient Manufacturing Systems Following its 2026 Annual Member Summit, AMGTA released Additive Manufacturing in Resource-Efficient Manufacturing Systems, an independent report establishing how additive manufacturing should be evaluated, communicated, and deployed across part,…
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis Organon a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced…
Horizon Quantum and AQT to Advance Real-World Quantum Applications with Strategic Hardware–Software Collaboration Horizon Quantum Computing Pte. Ltd., the wholly-owned subsidiary of Horizon Quantum Holdings Ltd.a pioneer of software infrastructure for quantum applications, and AQT (Alpine Quantum Technologies), a leading…
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced…
Atelerix Forms Strategic Partnership With JH Health Ltd to Expand Non-Cryogenic Cell Preservation Capabilities in the Middle East Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has established a…
Sutter Health Expands Use of Wearable Ultrasound Tech Across Additional Bay Area Hospitals to Advance Sepsis Care Sutter Health is expanding the use of FloPatch, the first wireless, wearable Doppler ultrasound device, across three additional Northern California hospitals: Sutter Solano…
VectorBuilder Introduces High-Stability MuteFree™ AAV to Improve Gene Therapy Manufacturing Reliability VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, announced MuteFree™ AAV, a high-stability AAV vector designed to address ITR instability, a common challenge in gene therapy…
Switch Automation and Berkeley Lab Advance Next Generation of Smart Buildings—From Analytics to Autonomous Operations Switch Automation, a global provider of smart building software, today announced the release of new product capabilities in Switch OpX (Operational Excellence), developed in collaboration…
ValGenesis Launches the Next Generation of VAL™, Bringing Governed AI to the Validation Lifecycle ValGenesis, the market leader in digital validation lifecycle management, announced the launch of the next generation of VAL™ (ValGenesis AI), designed to help life sciences companies…